After several years of further research, a recent mouse model of the most common SLC30A8 rare protein-truncating variant offered a potential mechanism for T2D protection, through increased first-phase insulin secretion [78•]. The gene discussed is SLC30A8; the disease is type 2 diabetes mellitus.